Form D · Venture Capital Fund
Mirae Asset Capital Life Science Inception I, LP
New York, NY · CIK 0002131585
Offering snapshot reported May 11, 2026 · SEC filing
- Reported sold
- $51M Offering amount: $51M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 20, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 11, 2026 | Initial | $51,000,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-583570
Source: Form D, filed May 11, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Young Hwan Kim | Executive |
| N/A Mirae Asset Capital Life Science Inc. | Executive |
| N/A Mirae Asset Capital Life Science Ventures I, Llc | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
1212 Avenue Of The Americas 10 Th Floor
New York, NY, 10036
New York, NY, 10036